Related references
Note: Only part of the references are listed.Triage of HPV positive women in cervical cancer screening
Nicolas Wentzensen et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
A Suggested Approach to Simplify and Improve Cervical Screening in the United States
Mark Schiffman et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2016)
HPV-Testing in Follow-up of Patients Treated for CIN2+Lesions
Luciano Mariani et al.
JOURNAL OF CANCER (2016)
Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
M. Arbyn et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results
Mark Schiffman et al.
GYNECOLOGIC ONCOLOGY (2015)
Multiple Biopsies and Detection of Cervical Cancer Precursors at Colposcopy
Nicolas Wentzensen et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
E. A. Joura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Increased Cervical Cancer Risk Associated With Screening at Longer Intervals
Walter Kinney et al.
OBSTETRICS AND GYNECOLOGY (2015)
Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection
Julia C. Gage et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
A Study of Genotyping for Management of Human Papillomavirus-Positive, Cytology-Negative Cervical Screening Results
M. Schiffman et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Clinical Performance of the BD Onclarity HPV Assay Using an Adjudicated Cohort of BD SurePath Liquid-Based Cytology Specimens
Thomas C. Wright et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions
Jack Cuzick et al.
JOURNAL OF CLINICAL VIROLOGY (2014)
Reassurance Against Future Risk of Precancer and Cancer Conferred by a Negative Human Papillomavirus Test
Julia C. Gage et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Five-Year Risks of CIN 3+and Cervical Cancer Among Women With HPV-Positive and HPV-Negative High-Grade Pap Results
Hormuzd A. Katki et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2013)
Five-Year Risks of CIN 3+and Cervical Cancer Among Women Who Test Pap-Negative But Are HPV-Positive
Hormuzd A. Katki et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2013)
Benchmarking CIN 3+Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines
Hormuzd A. Katki et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2013)
2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors
L. Stewart Massad et al.
OBSTETRICS AND GYNECOLOGY (2013)
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
Debbie Saslow et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer
Peng Guan et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
New Technologies and Procedures for Cervical Cancer Screening
Jack Cuzick et al.
VACCINE (2012)
Human Papillomavirus (HPV) Genotypes in Women with Cervical Precancer and Cancer at Kaiser Permanente Northern California
Philip E. Castle et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Evaluation of a New DNA Test for Detection of Carcinogenic Human Papillomavirus
Philip E. Castle et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice
Hormuzd A. Katki et al.
LANCET ONCOLOGY (2011)
Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study
Philip E. Castle et al.
LANCET ONCOLOGY (2011)
Evolutionary Dynamics of Variant Genomes of Human Papillomavirus Types 18, 45, and 97
Zigui Chen et al.
JOURNAL OF VIROLOGY (2009)
A review of human carcinogens-Part B: biological agents
Veronique Bouvard et al.
LANCET ONCOLOGY (2009)
Five-Year Experience of Human Papillomavirus DNA and Papanicolaou Test Cotesting
Philip E. Castle et al.
OBSTETRICS AND GYNECOLOGY (2009)
Impact of 6-month frozen storage of cervical specimens in alkaline buffer conditions on human papillomavirus genotyping
Brandon J. LaMere et al.
JOURNAL OF VIROLOGICAL METHODS (2008)
Human papillomavirus genotyping after denaturation of specimens for Hybrid Capture 2 testing: Feasibility study for the HPV persistence and progression cohort
Brandon J. LaMere et al.
JOURNAL OF VIROLOGICAL METHODS (2007)
Human papillomavirus and cervical cancer
Mark Schiffman et al.
LANCET (2007)
Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality
Melinda Butsch Kovacic et al.
CANCER RESEARCH (2006)
Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors:: Implications for screening and prevention
X Castellsagué et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Share Paper
